CorMedix Inc.
CRMD
Rank in Stocks
#12964
CorMedix Inc. is a biopharmaceutical company engaged in the development and... CorMedix Inc. is a biopharmaceutical company engaged in the development and commercialization of medical treatments for the prevention and care of infectious and inflammatory conditions, serving markets both in the United States and internationally. Its leading product candidate, DefenCath/Neutrolin, represents a novel anti-infective solution. This treatment aims to diminish and avert catheter-related infections and blood clots in patients who utilize central venous catheters for medical procedures such as hemodialysis, total parenteral nutrition, and oncology care. Incorporated in 2006, the company initially operated as Picton Holding Company, Inc. until officially adopting the name CorMedix Inc. in January 2007. Its corporate headquarters are located in Berkeley Heights, New Jersey.
Share Price
$5.47
Last synced: 2026-11-09
Market Cap
$426.36M
Change (1 day)
2.82%
Change (1 year)
-51.12%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade CorMedix Inc. (CRMD)
Category
Healthcare
EPS for CorMedix Inc. (CRMD)
EPS as of June 2026 TTM: $2.41
According to CorMedix Inc.'s latest financial reports, its current EPS (TTM) is $2.41. At the end of 2025 the company had an EPS of $2.25, an increase over its 2024 EPS of $-0.30.
EPS history for CorMedix Inc. from 2008 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $2.41 | 7.11% |
| 2025 | $2.25 | -850.00% |
| 2024 | $-0.30 | -67.03% |
| 2023 | $-0.91 | 22.97% |
| 2022 | $-0.74 | -1.33% |
| 2021 | $-0.75 | -2.60% |
| 2020 | $-0.77 | 13.24% |
| 2019 | $-0.68 | -54.97% |
| 2018 | $-1.51 | -49.50% |
| 2017 | $-2.99 | -8.00% |
| 2016 | $-3.25 | 12.07% |
| 2015 | $-2.90 | -39.20% |
| 2014 | $-4.77 | 44.55% |
| 2013 | $-3.30 | 120.00% |
| 2012 | $-1.50 | -48.98% |
| 2011 | $-2.94 | -48.96% |
| 2010 | $-5.76 | -87.85% |
| 2009 | $-47.40 | -11.27% |
| 2008 | $-53.42 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | 549.79% |
US
|
|
| $-7.07 | -393.36% |
US
|
|
| $-5.29 | -319.50% |
AU
|
|
| $12.88 | 434.44% |
BE
|
|
| $21.56 | 794.61% |
NL
|
Questions about CorMedix Inc.'s earnings per share (EPS)
What is CorMedix Inc.'s earnings per share (EPS)?
CorMedix Inc.'s earnings per share (EPS) over the last twelve months is $2.41, as of Jun 2026.
What was CorMedix Inc.'s earnings per share (EPS) in 2025?
In 2025, CorMedix Inc.'s earnings per share (EPS) was $2.25, compared with $-0.30 in 2024.
How has CorMedix Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, CorMedix Inc.'s earnings per share (EPS) was highest in 2025 ($2.25) and lowest in 2023 ($-0.91).
How does CorMedix Inc.'s earnings per share (EPS) compare with similar companies?
CorMedix Inc.'s earnings per share (EPS) ($2.41) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.